Animal studies have shown that, compared with monotherapy, combining BMS-986012 with platinum-etoposide chemotherapy or anti-PD-1 antibody can delay tumor growth, and the enhanced effect of BMS-986012 is likely mediated through NK cells and myeloid cells [39]. This evidence concerns the gene PDCD1 and neoplasm.